menu search

ZEAL / Why Zealand Pharma Shares Are Rising

Why Zealand Pharma Shares Are Rising
Zealand Pharma A/S - ADR (NASDAQ: ZEAL) shares are trading higher by 17.01% at $13.69 after the company announced the results from its phase 3 trial of Dasiglucagon in pediatric patients with congenital hyperinsulinism met the primary endpoint with statistical significance. Based on the trial's. Read More
Posted: May 19 2022, 10:41
Author Name: Benzinga
Views: 092051

ZEAL News  

Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results

By GlobeNewsWire
August 14, 2023

Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results

Press Release – No. 9 / 2023 Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results Copenhagen, D more_horizontal

Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results

By GlobeNewsWire
May 4, 2023

Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results

Press Release– No. 3 / 2023 Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results Copenhagen, Den more_horizontal

Zealand Pharma A/S (ZEAL) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 2, 2023

Zealand Pharma A/S (ZEAL) Q4 2022 Earnings Call Transcript

Zealand Pharma A/S (ZEAL) Q4 2022 Results Conference Call March 1, 2022 8:00 AM ET Company Participants Anna Krassowska - VP, IR Adam Steensberg - Pre more_horizontal

Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 11, 2022

Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Call Transcript

Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Anna Krassowska - Vice President, Invest more_horizontal

Why Zealand Pharma Shares Are Rising

By Benzinga
May 19, 2022

Why Zealand Pharma Shares Are Rising

Zealand Pharma A/S - ADR (NASDAQ: ZEAL) shares are trading higher by 17.01% at $13.69 after the company announced the results from its phase 3 trial o more_horizontal

Zealand Pharma A/S (ZEAL) CEO Adam Steensberg on Q1 2022 Earnings Call Transcript

By Seeking Alpha
May 12, 2022

Zealand Pharma A/S (ZEAL) CEO Adam Steensberg on Q1 2022 Earnings Call Transcript

Zealand Pharma A/S (ZEAL) Q1 2022 Earnings Conference Call May 12, 2022 10:00 AM ET Company Participants Matt Dallas - SVP and CFO Adam Steensberg - P more_horizontal


Search within

Pages Search Results: